1. Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/ΔNS2/Δ1313/I1314L and RSV/276 in RSV-Seronegative Children. (23rd June 2022) Authors: Cunningham, Coleen K; Karron, Ruth A; Muresan, Petronella; Kelly, Matthew S; McFarland, Elizabeth J; Perlowski, Charlotte; Libous, Jennifer; Oliva, Jennifer; Jean-Philippe, Patrick; Moye, Jack; Schappell, Elizabeth; Barr, Emily; Rexroad, Vivian; Johnston, Benjamin; Chadwick, Ellen G; Cielo, Mikha... Journal: Journal of infectious diseases Issue: Volume 226:Number 12(2022) Page Start: 2069 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study. Issue 6 (June 2017) Authors: Beigel, John H; Tebas, Pablo; Elie-Turenne, Marie-Carmelle; Bajwa, Ednan; Bell, Todd E; Cairns, Charles B; Shoham, Shmuel; Deville, Jaime G; Feucht, Eric; Feinberg, Judith; Luke, Thomas; Raviprakash, Kanakatte; Danko, Janine; O'Neil, Dorothy; Metcalf, Julia A; King, Karen; Burgess, Timothy H; Aga... Journal: Lancet Issue: Volume 5:Issue 6(2017) Page Start: 500 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children. (1st February 2020) Authors: McFarland, Elizabeth J; Karron, Ruth A; Muresan, Petronella; Cunningham, Coleen K; Perlowski, Charlotte; Libous, Jennifer; Oliva, Jennifer; Jean-Philippe, Patrick; Moye, Jack; Schappell, Elizabeth; Barr, Emily; Rexroad, Vivian; Fearn, Laura; Cielo, Mikhaela; Wiznia, Andrew; Deville, Jaime G; Yang... Journal: Journal of infectious diseases Issue: Volume 221:Number 12(2020) Page Start: 2050 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1–2 trial. Issue 5 (May 2022) Authors: Ruel, Theodore D; Acosta, Edward P; Liu, Jessica P; Gray, Kathryn P; George, Kathleen; Montañez, Nicole; Popson, Stephanie; Buchanan, Ann M; Bartlett, Mattie; Dayton, Dale; Anthony, Patricia; Brothers, Cynthia; Vavro, Cynthia; Singh, Rajendra; Koech, Lucy; Vhembo, Tichaona; Mmbaga, Blandina T; Pi... Journal: Lancet Issue: Volume 9:Issue 5(2022) Page Start: e332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗